Abstract |
Depressive disorders are frequently managed with long-term use of antidepressant medication. Even though the newer generation of selective serotonin reuptake inhibitor antidepressants exhibits a more favorable short-term, side-effect profile, effects of chronic use of such drugs remain unknown. Considering the limited data available on long-term, selective serotonin reuptake inhibitor management, we report for the first time on two cases of late-onset adverse effects occurring 6 and 10 years after chronic- fluoxetine treatment in which patients experienced symptoms of restlessness, tension, agitation, and sleep disturbances. Symptoms resolved after reduction or cessation of the medication. Our case reports suggest the existence of a late-onset side-effect profile, which appears similar to acute side-effect symptomatology. Super sensitivity of the serotonin-related receptors may develop over the long-term and account for the phenomenon. Careful clinical monitoring is recommended to detect any late-onset, medication-related side effects.
|
Authors | Nili Buchman, Rael D Strous, Yehuda Baruch |
Journal | Clinical neuropharmacology
(Clin Neuropharmacol)
2002 Jan-Feb
Vol. 25
Issue 1
Pg. 55-7
ISSN: 0362-5664 [Print] United States |
PMID | 11852298
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Serotonin Uptake Inhibitors
- Fluoxetine
|
Topics |
- Chronic Disease
- Depressive Disorder
(drug therapy)
- Female
- Fluoxetine
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Middle Aged
- Selective Serotonin Reuptake Inhibitors
(administration & dosage, adverse effects, therapeutic use)
- Time Factors
|